NCT04308395 2024-09-24Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)Sol-Gel Technologies, Ltd.Phase 3 Terminated108 enrolled 12 charts
NCT02303041 2019-01-29Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell CarcinomaStanford UniversityPhase 2 Terminated10 enrolled 11 charts